About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
DVAX - Dynavax Technologies...| Previous Close | $5.14 | Open | $5.15 |
| Volume | 3.68M | Market Cap | 566.29M |
| Yield | Last Dividend |
| Dynavax Announces Final Immunogenicity a... | 01/07/21 |
| EMERYVILLE, Calif., Jan. 7, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing an... | |
| Dynavax to Present at the H.C. Wainwrigh... | 01/06/21 |
| EMERYVILLE, Calif., Jan. 6, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing an... | |
| India's Biological E. to start vaccine l... | 12/18/20 |
| BENGALURU: India's Biological E. Ltd plans to start large late-stage trials of its potential COVID-19 vaccine candidate in April next year, according ... | |
| Clover Biopharmaceuticals Announces Posi... | 12/04/20 |
| CHENGDU, China.--(BUSINESS WIRE)--Clover Biopharmaceuticals, a global clinical-stage biotechnology company committed to developing transformative biol... | |
| Biological E to start phase-III trials b... | 11/24/20 |
| Hyderabad: Hyderabad-based Biological E, which recently obtained the drug regulator???s nod to start phase I and II clinical trials of its Covid-19 va... | |
| India's COVID-19 Vaccine COVAXIN's Final... | 11/22/20 |
| NEW DELHI ??? India ???s health minister said on Sunday a locally-developed COVID-19 vaccine candidate could complete its final trials in a month or t... | |
| Biological E. Limited Starts Phase I/II ... | 11/16/20 |
| HYDERABAD, India and HOUSTON and EMERYVILLE, Calif., Nov. 16, 2020 /PRNewswire/ -- Biological E. Limited (BE), a Hyderabad-based vaccines and pharmace... | |
| Dynavax Announces Third Quarter 2020 Fin... | 11/05/20 |
| EMERYVILLE, Calif., Nov. 5, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing an... | |
| Looking Into Dynavax Technologies's Retu... | 11/03/20 |
| During Q2, Dynavax Technologies's (NASDAQ: DVAX) reported sales totaled $2.67 million. Despite a 20.85% in earnings, the company posted a loss of $23.... | |
| Dynavax to Present at the Stifel 2020 Vi... | 11/02/20 |
| EMERYVILLE, Calif., Nov. 2, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing an... | |
| Dynavax to Report Third Quarter 2020 Fin... | 10/22/20 |
| EMERYVILLE, Calif., Oct. 22, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing a... | |
| Dynavax Surges 7% In Pre-Market On Taiwa... | 10/13/20 |
| Medigen Vaccine Biologics (MVC) and Dynavax Technologies (DVAX) have announced that MVC has obtained a Taiwan government subsidy for successfully init... | |
| Dynavax/Medigen's adjuvanted COVID-19 va... | 10/13/20 |
| Dynavax Technologies (NASDAQ:DVAX) and Medigen Vaccine Biologics (MVC) announce that latter has obtained a Taiwan government subsidy in amount of up t... | |
| Medigen's COVID-19 Vaccine Combined with... | 10/13/20 |
| TAPEI, Taiwan and EMERYVILLE, Calif., Oct. 13, 2020 /PRNewswire/ -- Medigen Vaccine Biologics Corporation (MVC) (TPEx: 6547.TWO), a biopharmaceutical ... | |
| Thinking about buying stock in Cassava S... | 09/14/20 |
| NEW YORK, Sept. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, MRSN, SRNE, DVAX, and CODX. To see how Investor... | |
| Worldwide Cancer Vaccines Industry to 20... | 09/08/20 |
| DUBLIN, Sept. 8, 2020 /PRNewswire/ -- The "Cancer Vaccines Market by Technology, Type, Indication and End User: Global Opportunity Analysis and Indust... | |
| Gates Foundation awards $3.4 million for... | 08/18/20 |
| The grant will enable biopharmaceutical company Dynavax Technologies Corporation to increase production capacity for its CpG 1018 advanced adjuvant an... | |
| Dynavax Technologies shares are trading ... | 08/03/20 |
| This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of ??... | |
| The Daily Biotech Pulse: Opko Wins CDC C... | 07/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb... | |
| Thinking about trading options or stock ... | 07/20/20 |
| NEW YORK, July 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DVAX, VXRT, ISRG, F, and LUV. Click a link below then ... | |
| 5 Stock Gainers for Friday: VBI Vaccines... | 07/17/20 |
| Stocks trading higher Friday include VBI Vaccines, Moderna, Novavax, Dynavax Technologies, and Quidel. | |
| The Daily Biotech Pulse: 2 IPOs, Nabriva... | 07/17/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 16) AC ... | |
| Early-stage stud underway on COVID-19 va... | 07/14/20 |
| Dynavax Technologies (NASDAQ:DVAX) jumps 10% premarket on modest volume in reaction to its announcement that dosing is underway in a Phase 1 clinical ... | |
| BRIEF-Dynavax Tech, Times Pharmacy Annou... | 07/10/20 |
| Dynavax Technologies Corp: | |
| The Daily Biotech Pulse: Ziopharm Starts... | 07/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affi... | |
| Thinking about trading options or stock ... | 06/26/20 |
| NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AXSM, SPCE, DVAX, BIG, and DIS. Click a link below the... | |
| Thinking about buying stock in Trevena, ... | 06/24/20 |
| NEW YORK, June 24, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TRVN, TBIO, WKHS, DVAX, and SEEL. To see how Investors... | |
| Dynavax to Present at the H.C. Wainwrigh... | 06/22/20 |
| EMERYVILLE, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developi... | |
| Thinking about buying stock in Salem Med... | 06/19/20 |
| NEW YORK, June 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SALM, DVAX, CLSN, HTZ, and MGM. To see how InvestorsOb... | |
| Dynavax Closes Enrollment in Renal Disea... | 06/10/20 |
| Dynavax (DVAX) is developing its hepatitis B vaccine, Heplisav-B, in patients with end-stage renal disease undergoing hemodialysis in a phase I study. | |
| Buy rating | 11/06/20 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $12.00 to $14.00 | |
| Date | 2020-11-05 (AMC) | Est. (EPS/Rev.) | ($0.20)/ 9.44M |
| Actual (EPS/Rev.) | $-0.15/ $13.41 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| WIDE AWAKE | JOHN KROLIKOWSKI JR | 79.00 % | Follow |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| 1035even | Evan Earle | 61.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
